NCT06641960

Brief Summary

Fifty patients needing non-extraction-based metallic orthodontic treatment will be divided randomly into the probiotic group and the control group. In each group, they will brush their teeth regularly while receiving orthodontic treatment. Only the probiotic group will take probiotic tablets for six months. Clinical parameters will be assessed before and during orthodontic treatment and after 3 and 6 months during treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 5, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 6, 2023

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 17, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

October 11, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 15, 2024

Completed
Last Updated

October 16, 2024

Status Verified

October 1, 2024

Enrollment Period

5 months

First QC Date

October 11, 2024

Last Update Submit

October 14, 2024

Conditions

Outcome Measures

Primary Outcomes (4)

  • The change in the plaque index

    Assessment will be achieved using a gingival probe, according to Silness and Loe (1964). The criteria for plaque index are as follows: 0\. No plaque 1. A film of plaque adheres to the free gingival margin and adjacent area of the tooth. The plaque may be seen in situ only after the application of the disclosing solution or by using a probe on the tooth surface. 2. Moderate accumulation of soft deposits within the gingival pocket, or the tooth and the gingival margin, which can be seen with the naked eye. 3. An abundance of soft matter within the gingival pocket and/or the tooth and gingival margin.

    Time Frame: T0: immediately before applying the fixed appliance; T1: at three months; T2: at six months

  • The change in the gingival index

    Assessment will be achieved using a gingival probe, according to Silness and Loe (1964). The criteria for the gingival index are as follows: 0\. Normal gingiva. 1. Mild inflammation: a slight change in color, slight edema, no bleeding on probing. 2. Moderate inflammation: moderate glazing, redness, edema, hypertrophy, bleeding on probing. 3. Severe inflammation: marked redness and hypertrophic ulceration, tendency to spontaneous bleeding.

    Time Frame: T0: immediately before applying the fixed appliance; T1: at three months; T2: at six months

  • The change in papillary bleeding index

    Assessment will be achieved using a gingival probe, according to Muhlemann (1977). 0\. No bleeding. 1. A single discreet bleeding point appears. 2. Several isolated bleeding points or a single fine line of blood appear. 3. The interdental triangle fills with blood shortly after probing. 4. Profuse bleeding occurs after probing; blood flows immediately into the marginal sulcus.

    Time Frame: T0: immediately before applying the fixed appliance; T1: at three months; T2: at six months

  • The change in the probing depth

    Assessment will be achieved using a gingival probe, according to Bowers (1964). It will be measured clinically as the distance from the free gingival margin to the gingival sulcus. The reading of PD ≤3 mm was considered normal, while any reading \>3 mm was considered a gingival pocket

    Time Frame: T0: immediately before applying the fixed appliance; T1: at three months; T2: at six months

Study Arms (2)

Probiotics group

EXPERIMENTAL

In this group, the patients will undergo orthodontic treatment with metallic appliances and receive oral hygiene instruction with probiotic lozenges.

Drug: Probiotics

The control group without Probiotics

ACTIVE COMPARATOR

In this group, the patients will undergo orthodontic treatment with metallic appliances and receive oral hygiene instruction without probiotic lozenges.

Procedure: Traditional treatment

Interventions

In this group, the patients will undergo orthodontic treatment with metallic appliances and receive oral hygiene instruction with probiotic lozenges.

Probiotics group

In this group, the patients will undergo orthodontic treatment with metallic appliances and receive oral hygiene instruction without probiotic lozenges.

The control group without Probiotics

Eligibility Criteria

Age18 Years - 25 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Adult healthy male and female patients aged 18-25 years.
  • Patients eligible for full arch upper and lower fixed labial orthodontic appliance treatment and molar band.
  • Patients with malocclusion class I, II, or III without crowding on the anterior teeth.
  • Permanent occlusion and existence of all the upper and lower teeth (except third molars).
  • Good oral and periodontal health:
  • Probing depth \< 4 mm
  • No radiographic evidence of bone loss.
  • Gingival index ≤ 1
  • Plaque index ≤ 1

You may not qualify if:

  • Previous orthodontic treatment history.
  • Patients with any systemic disorder that could influence periodontal conditions or response to treatment (such as hypertension, diabetes, or immunological disorders).
  • Patients were on systemic drugs, i.e., antibiotics, hypertensives, analgesics, hormonal drugs, sedatives, and anti-seizure medication, within three months before the baseline examination.
  • Patients who were allergic to ingredients of the probiotics lozenges.
  • Those undergoing periodontal treatment within three months before the baseline examination.
  • Smokers, pregnant or lactating women.
  • Regular use of antibacterial mouthwash.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Orthodontics, Faculty of Dentistry, University of Damsacus

Damascus, DM20 HAJ72, Syria

Location

Related Publications (5)

  • Cerroni S, Pasquantonio G, Condo R, Cerroni L. Orthodontic Fixed Appliance and Periodontal Status: An Updated Systematic Review. Open Dent J. 2018 Sep 28;12:614-622. doi: 10.2174/1745017901814010614. eCollection 2018.

    PMID: 30369970BACKGROUND
  • Contaldo M, Lucchese A, Lajolo C, Rupe C, Di Stasio D, Romano A, Petruzzi M, Serpico R. The Oral Microbiota Changes in Orthodontic Patients and Effects on Oral Health: An Overview. J Clin Med. 2021 Feb 16;10(4):780. doi: 10.3390/jcm10040780.

    PMID: 33669186BACKGROUND
  • Agossa K, Dubar M, Lemaire G, Blaizot A, Catteau C, Bocquet E, Nawrocki L, Boyer E, Meuric V, Siepmann F. Effect of Lactobacillus reuteri on Gingival Inflammation and Composition of the Oral Microbiota in Patients Undergoing Treatment with Fixed Orthodontic Appliances: Study Protocol of a Randomized Control Trial. Pathogens. 2022 Jan 18;11(2):112. doi: 10.3390/pathogens11020112.

    PMID: 35215057BACKGROUND
  • Freitas AO, Marquezan M, Nojima Mda C, Alviano DS, Maia LC. The influence of orthodontic fixed appliances on the oral microbiota: a systematic review. Dental Press J Orthod. 2014 Mar-Apr;19(2):46-55. doi: 10.1590/2176-9451.19.2.046-055.oar.

    PMID: 24945514BACKGROUND
  • Santonocito S, Polizzi A. Oral Microbiota Changes during Orthodontic Treatment. Front Biosci (Elite Ed). 2022 Jul 27;14(3):19. doi: 10.31083/j.fbe1403019.

    PMID: 36137992BACKGROUND

MeSH Terms

Interventions

Probiotics

Intervention Hierarchy (Ancestors)

Dietary SupplementsFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Lana Hasan Albardwel, DDS

    Department of Orthodontics, Faculty of Dentistry, University of Damascus, Damascus , Syria

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 11, 2024

First Posted

October 15, 2024

Study Start

March 5, 2023

Primary Completion

August 6, 2023

Study Completion

June 17, 2024

Last Updated

October 16, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations